Prudential Financial »

Context Therapeutics shares owned by Prudential Financial

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Prudential Financial from 13F filings

Historical chart of Prudential Financial investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Prudential Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Prudential Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.4k 13k 0.55

More positions owned by Prudential Financial

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Dimensional Etf Trust Us Equi Mark Et (DFUS)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Pgim Etf Tr Pgim Ultra Sh B (PULS)
Ishares Tr Iboxx Inv Cp Et (LQD)
Micron Technology (MU)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Prudential Financial

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics